BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29804279)

  • 1. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy.
    Min KA; Maharjan P; Ham S; Shin MC
    Arch Pharm Res; 2018 Jun; 41(6):594-616. PubMed ID: 29804279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted drug delivery for breast cancer treatment.
    Jin S; Ye K
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):143-53. PubMed ID: 23394116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of peptides as potential drugs for cancer therapy.
    Li ZJ; Cho CH
    Curr Pharm Des; 2010; 16(10):1180-9. PubMed ID: 20166989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of intracellular-acting biologics in pro-apoptotic therapies.
    Li H; Nelson CE; Evans BC; Duvall CL
    Curr Pharm Des; 2011; 17(3):293-319. PubMed ID: 21348831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of apoptosis pathways in cancer.
    Ziegler DS; Kung AL
    Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.
    Pistritto G; Trisciuoglio D; Ceci C; Garufi A; D'Orazi G
    Aging (Albany NY); 2016 Apr; 8(4):603-19. PubMed ID: 27019364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic Peptides for the Treatment of Cancer.
    Mine Y; Munir H; Nakanishi Y; Sugiyama D
    Anticancer Res; 2016 Jul; 36(7):3565-70. PubMed ID: 27354624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venom Peptides: Improving Specificity in Cancer Therapy.
    Mahadevappa R; Ma R; Kwok HF
    Trends Cancer; 2017 Sep; 3(9):611-614. PubMed ID: 28867164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.
    Hata AN; Engelman JA; Faber AC
    Cancer Discov; 2015 May; 5(5):475-87. PubMed ID: 25895919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-induced apoptosis in primary tumors.
    McConkey DJ
    Adv Exp Med Biol; 2007; 608():31-51. PubMed ID: 17993231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 family proteins as targets for anticancer drug design.
    Huang Z
    Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Use of Peptides in Cancer Treatment.
    Yavari B; Mahjub R; Saidijam M; Raigani M; Soleimani M
    Curr Protein Pept Sci; 2018; 19(8):759-770. PubMed ID: 29332577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
    Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
    Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and medicinal chemistry approaches towards various apoptosis inducers.
    Vyas VK; Chintha C; Pandya MR
    Anticancer Agents Med Chem; 2013 Mar; 13(3):433-55. PubMed ID: 22721391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
    Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel genetic and peptide-based strategies targeting the Bcl-2 family, an update.
    Aouacheria A
    Recent Pat DNA Gene Seq; 2009; 3(2):123-9. PubMed ID: 19519582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer therapeutics: Targeting the apoptotic pathway.
    Khan KH; Blanco-Codesido M; Molife LR
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.